C50.119
Malignant neoplasm of central portion of unspecified female breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the central portion of the female breast, classified under ICD-10 code C50.119, refers to a type of breast cancer that originates in the central area of the breast tissue. This condition involves the abnormal growth of malignant cells and can affect the ductal structures and surrounding tissues. Recognizing the characteristics and understanding the implications of this diagnosis are essential for managing the condition effectively. The central part of the breast includes the areola and the nipple, making tumors in this area potentially more noticeable due to their proximity to these prominent features.
Causes & Symptoms
Clinical Causes: Genetic mutations, such as BRCA1 and BRCA2 gene alterations Hormonal factors, including prolonged exposure to estrogen Environmental influences like radiation exposure Lifestyle choices, such as excessive alcohol consumption and obesity History of previous breast diseases or radiation therapy
Key Symptoms: Lump or mass located centrally within the breast Changes in the skin over the breast, such as redness or dimpling Nipple abnormalities, including inversion, discharge, or ulceration Persistent pain or discomfort in the central breast area Swelling or thickening of the breast tissue
Diagnostic & Treatment
Diagnosis Path: Clinical breast examination to detect physical abnormalities Mammography imaging to visualize the internal breast structures Ultrasound to differentiate between cystic and solid masses Biopsy procedures, such as core needle biopsy, for tissue sampling Magnetic resonance imaging (MRI) for detailed assessment, especially in ambiguous cases Lymph node evaluation to check for spread of cancer
Treatment Protocols: Surgical options, including lumpectomy or mastectomy, to remove the tumor Radiation therapy to destroy remaining cancer cells post-surgery Chemotherapy to target cancer cells throughout the body Hormonal therapy for hormone-receptor-positive tumors Targeted therapy aimed at specific genetic mutations within the cancer cells Supportive care to manage side effects and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C50.119 a billable ICD-10 code?
Yes, C50.119 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.119?
Clinical documentation must specify the nature of Malignant neoplasm of central portion of unspecified female breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference